Shevah O, Borrelli P, Rubinstein M, Laron Z
Endocrine and Diabetes Research Unit, Schneider Children's Medical Center, Tel-Aviv University, Israel.
J Endocrinol Invest. 2003 Jul;26(7):604-8. doi: 10.1007/BF03347015.
Deletions and mutations in the growth hormone receptor gene are the underlying etiology of Laron syndrome (LS). Most of the patients are distributed in and originating from the Mediterranean and Middle-Eastern countries. Thirty-nine mutations have been described so far. We hereby report 2 novel nonsense mutations, one in exon 2 found in three Jewish-Iraqi patients from Israel; and another in exon 6 found in an Italian girl. DNA sequencing of exon 2 revealed a G to A transition at nucleotide 83 in the fourth codon of the signal peptide (W-15X). In exon 6, a T to A transversion was found in amino acid 141 (L141X). Both mutations introduced a premature termination codon that led to a truncated non-functioning receptor. In addition we found in the Jewish-Iraqi patients, a mutation in exon 7 (R211H, previously described) and in the Italian family the polymorphism Gly168, in exon 6.
生长激素受体基因的缺失和突变是拉伦综合征(LS)的根本病因。大多数患者分布在地中海和中东国家并起源于此。迄今为止已描述了39种突变。我们在此报告2种新的无义突变,一种在第2外显子中,发现于3名来自以色列的伊拉克犹太患者;另一种在第6外显子中,发现于一名意大利女孩。第2外显子的DNA测序显示信号肽第4密码子(W-15X)的核苷酸83处发生了G到A的转换。在第6外显子中,在氨基酸141处发现了T到A的颠换(L141X)。这两种突变都引入了过早的终止密码子,导致受体截短且无功能。此外,我们在伊拉克犹太患者中发现了第7外显子中的一种突变(R211H,先前已描述),在意大利家族中发现了第6外显子中的Gly168多态性。